Our findings highlight the importance of Sp1/miR-130b-3p/HOXA5 axis in tumor angiogenesis and recurrence, and implicate HOXA5 as a potential target for HCC treatment. This evidence concerns the gene HOXA5 and hepatocellular carcinoma.